DIA/EFGCP/EMA Conference on How to Optimise Children’s Access to Innovative Medicines? Back
This year’s DIA/EFGCP/EMA annual paediatric conference will focus on ways to overcome the challenges and successes from the past 10 years of paediatric regulation. The conference in 2017 will also discuss the access angle: how can the medicines be brought to the patients in real life? Processes such as scientific advice and conditional licensing will be discussed, together with case studies from therapeutic areas where paediatric programmes have been challenging to complete. The conference will seek solutions to take to your organisation, host an open dialogue with all parties for the benefit of the patients.
- Update participants on current paediatric regulatory requirements, scientific and operational success and challenges
- Exchange experiences with regulatory authorities, academia and industry
- Discuss visions, daily challenges and potential ways to move forward and further improve processes for paediatric drug development